Phase 1 pharmacokinetic and pharmacodynamic clinical study of nitric oxide releasing aspirin, WS #46
Ended Definitive Contract Awarded Last action
- Contract number
- 00261200302D261035110
- Awardee
-
University Of Michigan UEI NKHYP5XEBMG6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,271,987
Award facts
- Contract value 9% obligated
-
- $21,163,091.00 Current, with exercised options
- $26,194,881.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer
- Pricing
- Cost No Fee
- Place of performance
- Ann Arbor, MI 48109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $20,000 | |
| Funding Only Action | $977,642 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $708,879 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $565,466 |
Show all 15
About this award
This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to the University of Michigan for a Phase 1 pharmacokinetic and pharmacodynamic clinical study of a nitric oxide releasing aspirin compound, with a ceiling value of $26,194,881.00. The contract was awarded on February 15, 2003 with a completion date of February 17, 2011. It is a cost-no-fee contract and was not subject to a set-aside requirement. The contract appears to be related to the NCI's research and development activities in the area of cancer treatments involving nitric oxide.
Quick answers
Who was awarded contract 00261200302D261035110?
00261200302D261035110 was awarded to University Of Michigan by National Cancer Institute (National Institutes of Health) on February 15, 2003.
How much is contract 00261200302D261035110 worth?
The government has obligated $2,271,987 on 00261200302D261035110. Its current value, with exercised options, is $21,163,091. Its potential value, with all options, is $26,194,881.
Was contract 00261200302D261035110 competed?
The extent of competition for 00261200302D261035110 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award